Vivlion GmbH Press Releases

• Published on December 11, 2024 - 15:00 GMT

  

  Vivlion® launches fixed-pair Alexandria, a genome-wide PRCISR™ CRISPR library with unmatched accuracy and precision

  Accelerating drug discovery by CRISPR-based screening technologies FRANKFURT, GERMANY, December 11, 2024 /⁨EINPresswire.com⁩/ -- Vivlion GmbH, a leader in CRISPR-based screening technologies, today announced the launch of its new flagship fixed-pair …

  Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...
• Published on May 11, 2023 - 17:00 GMT

  

  Vivlion® to provide services to Repare Therapeutics on advanced PRCISR™ CRISPR gRNA libraries

  FRANKFURT, HESSE, GERMANY, May 11, 2023 /⁨EINPresswire.com⁩/ -- Vivlion GmbH, a German biotech company providing next-generation gene editing solutions, today announced an agreement to provide services for the generation of advanced gRNA libraries for …

  Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...
• Published on February 14, 2022 - 13:00 GMT

  

  Vivlion® launches fixed-pair technology for combinatorial gene editing and screens

  Significant expansion of proprietary CRISPR multiplexing platform to serve customers worldwide FRANKFURT AM MAIN, GERMANY, February 14, 2022 /⁨EINPresswire.com⁩/ -- Vivlion GmbH, a Germany-based biotech company providing next generation gene editing …

  Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...
• Published on March 1, 2021 - 14:00 GMT

  

  Vivlion® licenses CRISPR/Cas9 patent portfolio from Broad Institute

  FRANKFURT AM MAIN, GERMANY, March 1, 2021 /⁨EINPresswire.com⁩/ -- Vivlion GmbH today announced the execution of a non-exclusive license agreement with the Broad Institute of MIT and Harvard. The agreement provides Vivlion with access to CRISPR/Cas9 …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...